Gene · 7477
Papers1,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development. | Front Immunol | 2022 | 36003399 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals crucial regulatory roles of immediate-early response genes and related signaling pathways in coronavirus infectious bronchitis virus infection. | Virology | 2022 | 35987078 | PubTator, text mining | PubMed |
| Involvement of the Wnt pathway in BVDV cytopathogenic strain replication in primary bovine cells. | Virol J | 2022 | 35986298 | PubTator, text mining | PubMed |
| Validation and analysis of expression, prognosis and immune infiltration of WNT gene family in non-small cell lung cancer. | Front Oncol | 2022 | 35957916 | PubTator, text mining | PubMed |
| Single-cell multi-omics of human preimplantation embryos shows susceptibility to glucocorticoids. | Genome Res | 2022 | 35948369 | PubTator, text mining | PubMed |
| All trans-retinoic acid modulates hyperoxia-induced suppression of NF-kB-dependent Wnt signaling in alveolar A549 epithelial cells. | PLoS One | 2022 | 35947545 | PubTator, text mining | PubMed |
| The SWI/SNF chromatin remodeling factor DPF3 regulates metastasis of ccRCC by modulating TGF-β signaling. | Nat Commun | 2022 | 35945219 | PubTator, text mining | PubMed |
| Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment. | Mol Cancer Ther | 2022 | 35930737 | PubTator, text mining | PubMed |
| HOTAIR interacts with PRC2 complex regulating the regional preadipocyte transcriptome and human fat distribution. | Cell Rep | 2022 | 35905723 | PubTator, text mining | PubMed |
| Chimeric Oncolytic Adenovirus Armed Chemokine Rantes for Treatment of Breast Cancer. | Bioengineering (Basel) | 2022 | 35892755 | PubTator, text mining | PubMed |
| Vitamin A in Skin and Hair: An Update. | Nutrients | 2022 | 35889909 | PubTator, text mining | PubMed |
| Effects of Spore-Displayed p75 Protein from Lacticaseibacillus rhamnosus GG on the Transcriptional Response of HT-29 Cells. | Microorganisms | 2022 | 35888995 | PubTator, text mining | PubMed |
| Role of Circular RNA in Brain Tumor Development. | Cells | 2022 | 35883576 | PubTator, text mining | PubMed |
| Interaction Between Intrinsic Renal Cells and Immune Cells in the Progression of Acute Kidney Injury. | Front Med (Lausanne) | 2022 | 35872775 | PubTator, text mining | PubMed |
| TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR. | Int J Biol Sci | 2022 | 35864968 | PubTator, text mining | PubMed |
| Identification and implication of tissue-enriched ligands in epithelial-endothelial crosstalk during pancreas development. | Sci Rep | 2022 | 35864120 | PubTator, text mining | PubMed |
| RNA N6-Methyladenine Modification, Cellular Reprogramming, and Cancer Stemness. | Front Cell Dev Biol | 2022 | 35859892 | PubTator, text mining | PubMed |
| FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling. | Mol Med | 2022 | 35854234 | PubTator, text mining | PubMed |
| Tumor specificity of WNT ligands and receptors reveals universal squamous cell carcinoma oncogenes. | BMC Cancer | 2022 | 35850748 | PubTator, text mining | PubMed |
| Limitation and challenges in using pancreatic cancer-derived organoids as a preclinical tool. | Cancer Commun (Lond) | 2022 | 35848462 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7477/papers?page=19